Search results for: Health Policy and Regulation
Filter search results
Oriol de Solà-Morales
30 August 2023
Oriol has built a career in the planning, policy and decision-making environment, participating not just in the micro management, but also being deeply involved on the meso and macro policy…
Christopher Henshall
30 August 2023
…responsible for promoting enterprise and innovation and links with government and businesses, and served as Chair of the York Health Economics Consortium). He was the Founding President of Health Technology…
Professor Graham Cookson Appointed OHE Director Designate
24 April 2018
…of Economic & Public Policy and Head of the Department of Health Care Management & Policy at University of Surrey. There he won major health research grants from the EU…
Richard Torbett
3 February 2023
Dr Richard Torbett joined ABPI in July 2015 and previously held the role of Executive Director of Economic, Health and Commercial Policy. In this role, Richard was responsible for pricing…
Bhaven N. Sampat
20 January 2023
Bhaven N. Sampat is an economist by training, a Professor at the Department of Health Policy and Management at Columbia University, and a Research Associate at the National Bureau of…
Gene Therapy: Understanding the Science, Assessing the Evidence, and Paying for Value
1 March 2017
…costs. The 2016 ICER Policy Summit convened an influential group of evidence policy leaders from insurers, pharmacy benefit management firms, and life science companies to discuss gene therapies and to…
Recommendations for Making Outcome-based Payments a Reality in the NHS: An Application to Cancer Drugs
21 February 2019
Making Outcome-based payments a reality in the NHS authored by The Office of Health Economics, RAND Europe, King’s College London, and Cancer Research UK, and commissioned by Cancer Research UK…
Politics of Prescribing
1 January 1985
…of the seven most successful countries in the world in its record of pharmaceutical innovation. The other six are the United States, West Germany, Switzerland, France, Italy and Japan. No…
Indication-Based Pricing: Are We All Onboard?
12 May 2020
…https://www.ohe.org/publications/multi-indication-pricing-mip-practical-solutions-and-steps-move-forward# Mestre-Ferrandiz,J., Towse, A., Dellamano, R., and Pistollato, M. (2015). Multi-indication Pricing: Pros, Cons and Applicability to the UK. Seminar Briefing 56. Office of Health Economics. Available at: https://www.ohe.org/publications/multi-indication-pricing-pros-cons-and-applicability-uk …